economy
shanghai unveils new measures to bolster biopharma sector
local innovative pharmaceutical or medical devices companies will also receive no more than 30 percent of the r d expense of up to 10 million yuan for new products that have gained approval from the united states food and drug administration the european medicines agency and the japanese pharmaceuticals and medical devices agency or other medical regulatory agencies from brics countries and belt and road initiative...
1m
